GB1479964A - 2,3-methylene prostaglandins and their preparation - Google Patents

2,3-methylene prostaglandins and their preparation

Info

Publication number
GB1479964A
GB1479964A GB30268/74A GB3026874A GB1479964A GB 1479964 A GB1479964 A GB 1479964A GB 30268/74 A GB30268/74 A GB 30268/74A GB 3026874 A GB3026874 A GB 3026874A GB 1479964 A GB1479964 A GB 1479964A
Authority
GB
United Kingdom
Prior art keywords
formula
alkyl
compounds
radical
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB30268/74A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH995973A external-priority patent/CH599147A5/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB1479964A publication Critical patent/GB1479964A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1479964 2,3-Methyleneprostaglandins SANDOZ Ltd 8 July 1974 [9 July 1973 4 May 1974] 30268/74 Heading C2C [Also in Division C3] The invention comprises optically active 2,3- methyleneprostaglandins of the formulµ or racemates thereof, wherein R 1 is H, C 1-8 alkyl, C 3-10 cycloalkyl or C 7-12 aralkyl, R 2 and R 3 each are H or C 1-4 alkyl, R 4 is 2-tetrahydropyranyl, R 6 is H, C 1-8 alkyl, C 3-10 cycloalkyl or C 7-12 aralkyl, and D is one of the four carbocyclic radicals IIa to IId and A is a carbocyclic radical of Formula IIa or IIb above or of the formula IIe or IIf and salts thereof when R 1 is H and their preparation. The compounds of Formula I above are prepared by hydrolysing the corresponding compound of Formula III, or when D is a radical of the Formula IIb by the acidic dehydration of compound of Formula I above in which D is a carbocyclic radical of the Formula IId. The esters and acids of the compound of Formula I above are obtained by esterification of the corresponding free acids and hydrolysis of the appropriate esters respectively. Compounds of the Formula III above in which A is a carbocyclic radical of the Formula IIa, IIb or IIf are obtained by oxidizing the corresponding compounds of Formula III in which A is a carbocyclic radical of the Formula IIe above or IIg or IIh Compound of Formula III in which A is a carbocyclic radical of the Formula IIe are prepared by reacting compounds of the formula E-CH=CH-CH(OR 4 )-C(R 2 )R 3 -(CH 2 ) 3 CH 3 wherein E is a radical of the Formula Vc with phosphonium halides of the Formula VI wherein X is Cl, BrI and R 5 is naphthyl or phenyl optionally substituted by alkyl, or alkyl. Pharmaceutical compositions contain the above 2,3-methylene prostaglandins of the Formula I above in association with pharmaceutical carriers or diluents. The compounds possess prostaglandin-like activity.
GB30268/74A 1973-07-09 1974-07-08 2,3-methylene prostaglandins and their preparation Expired GB1479964A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH995973A CH599147A5 (en) 1973-07-09 1973-07-09 Long-acting synthetic prostaglandins
CH604974 1974-05-04

Publications (1)

Publication Number Publication Date
GB1479964A true GB1479964A (en) 1977-07-13

Family

ID=25698889

Family Applications (2)

Application Number Title Priority Date Filing Date
GB1901/77A Expired GB1479965A (en) 1973-07-09 1974-07-08 Cyclopropane carboxylic acid derivatives
GB30268/74A Expired GB1479964A (en) 1973-07-09 1974-07-08 2,3-methylene prostaglandins and their preparation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB1901/77A Expired GB1479965A (en) 1973-07-09 1974-07-08 Cyclopropane carboxylic acid derivatives

Country Status (15)

Country Link
JP (1) JPS5040549A (en)
AT (1) AT355233B (en)
CA (1) CA1050976A (en)
DD (1) DD113348A5 (en)
DE (1) DE2431930A1 (en)
DK (1) DK142143B (en)
ES (2) ES428063A1 (en)
FI (1) FI58117C (en)
FR (2) FR2236490B1 (en)
GB (2) GB1479965A (en)
IE (1) IE41342B1 (en)
IL (1) IL45215A (en)
NL (1) NL7409119A (en)
NO (1) NO742378L (en)
SE (2) SE7408689L (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2638401A1 (en) * 1975-09-05 1977-03-17 Sandoz Ag NEW PROSTAGLANDIN, THEIR USE AND MANUFACTURING
JPS52116930U (en) * 1976-03-03 1977-09-05
JPS55147056U (en) * 1979-04-06 1980-10-22
US4431669A (en) * 1982-12-17 1984-02-14 Schering Corporation Cyclopropyl substituted polyenes
JPH04204679A (en) * 1990-11-30 1992-07-27 Fuji Photo Film Co Ltd Electrophotographic image recorder

Also Published As

Publication number Publication date
IE41342B1 (en) 1979-12-05
GB1479965A (en) 1977-07-13
DK142143C (en) 1981-02-09
SE7408689L (en) 1975-01-10
DK352974A (en) 1975-03-03
CA1050976A (en) 1979-03-20
IL45215A0 (en) 1975-02-10
DE2431930A1 (en) 1975-01-30
FR2236490B1 (en) 1978-07-21
DD113348A5 (en) 1975-06-05
FI58117B (en) 1980-08-29
SE7512194L (en) 1975-10-30
NO742378L (en) 1975-02-03
FR2236490A1 (en) 1975-02-07
AT355233B (en) 1980-02-25
ES448000A1 (en) 1977-11-01
ES428063A1 (en) 1977-02-01
JPS5040549A (en) 1975-04-14
FI201174A (en) 1975-01-10
ATA559874A (en) 1979-07-15
FR2318169B1 (en) 1978-11-03
IL45215A (en) 1977-07-31
NL7409119A (en) 1975-01-13
DK142143B (en) 1980-09-08
IE41342L (en) 1975-01-09
FI58117C (en) 1980-12-10
FR2318169A1 (en) 1977-02-11

Similar Documents

Publication Publication Date Title
US4096179A (en) 13,14-Dihydro-16-phenoxy prostaglandin F1α analogs
JPS5444639A (en) Prostaglandin analog and its preparation
GB1282661A (en) Prostaglandins and the manufacture thereof
GB1501632A (en) Aromatic ketones having cardiovascular activity
GB1479964A (en) 2,3-methylene prostaglandins and their preparation
GB1448316A (en) Racemization of optically active 2,2-dimethyl-3,1,-alkenyl- cyclopropane-1-carboxylic acids
GB1424415A (en) Prostaglandin intermediates and their preparation
GB1252329A (en)
GB1496491A (en) Dihydroergopeptine derivatives
GB1484088A (en) Indane acetic acids and esters
GB1415219A (en) Oxabicyclooctanes and process for their manufacture
GB1429039A (en) Dialkylphosphinyl compounds
GB1502569A (en) Cyclopropane derivatives
GB1345934A (en) Cyclopentane derivatives
GB1246953A (en) Polymeric sulphonic acids and salts
GB1424806A (en) Cyclopentane derivatives
JPS5419946A (en) Prostaglandin analog compound and their preparation
SE7408868L (en)
GB1529852A (en) 8-azaprostaglandins and process for the preparation thereof
GB1308650A (en) Cyclopropane carboxylic acid derivatives
GB1508925A (en) 1,5-inter-(2,5-thienylene)-2,3,4,17,18,19,20-heptanorprostaglandins
GB1363692A (en) Benzothiazolyl acetic acid derivatives
SE7608223L (en) PROCEDURE FOR THE MANUFACTURE OF OXAPROSTAGLANDINS
GB1425808A (en) Pharmaceutically useful prostanoic acid derivatives
GB1350645A (en) Phenylacetic acid derivatives a method for their preparation and the applications thereof

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee